nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—CTSG—blood plasma—bipolar disorder	0.0389	0.0867	CbGeAlD
Bortezomib—PSMD1—adrenal cortex—bipolar disorder	0.0159	0.0355	CbGeAlD
Bortezomib—CYP2C19—urine—bipolar disorder	0.0146	0.0324	CbGeAlD
Bortezomib—PSMD2—adrenal cortex—bipolar disorder	0.0141	0.0314	CbGeAlD
Bortezomib—PSMB8—adrenal cortex—bipolar disorder	0.014	0.0312	CbGeAlD
Bortezomib—PSMA1—thyroid gland—bipolar disorder	0.0132	0.0294	CbGeAlD
Bortezomib—PSMB5—adrenal cortex—bipolar disorder	0.0124	0.0276	CbGeAlD
Bortezomib—CYP1A2—urine—bipolar disorder	0.0119	0.0265	CbGeAlD
Bortezomib—CYP2C9—urine—bipolar disorder	0.0113	0.0251	CbGeAlD
Bortezomib—PSMA1—nervous system—bipolar disorder	0.0111	0.0247	CbGeAlD
Bortezomib—PSMD1—thyroid gland—bipolar disorder	0.0111	0.0247	CbGeAlD
Bortezomib—PSMB1—adrenal cortex—bipolar disorder	0.0108	0.0241	CbGeAlD
Bortezomib—PSMB2—adrenal cortex—bipolar disorder	0.0106	0.0235	CbGeAlD
Bortezomib—PSMA1—cerebellum—bipolar disorder	0.0105	0.0233	CbGeAlD
Bortezomib—PSMD2—thyroid gland—bipolar disorder	0.00983	0.0219	CbGeAlD
Bortezomib—PSMB8—thyroid gland—bipolar disorder	0.00977	0.0217	CbGeAlD
Bortezomib—SLC31A1—adrenal cortex—bipolar disorder	0.00915	0.0204	CbGeAlD
Bortezomib—PSMD1—cerebellum—bipolar disorder	0.00879	0.0195	CbGeAlD
Bortezomib—PSMB5—thyroid gland—bipolar disorder	0.00863	0.0192	CbGeAlD
Bortezomib—CYP3A4—urine—bipolar disorder	0.00861	0.0192	CbGeAlD
Bortezomib—PSMA1—brain—bipolar disorder	0.0085	0.0189	CbGeAlD
Bortezomib—CYP2D6—urine—bipolar disorder	0.00847	0.0189	CbGeAlD
Bortezomib—PSMD2—nervous system—bipolar disorder	0.00827	0.0184	CbGeAlD
Bortezomib—PSMD2—cerebellum—bipolar disorder	0.00778	0.0173	CbGeAlD
Bortezomib—CYP2C19—blood plasma—bipolar disorder	0.0076	0.0169	CbGeAlD
Bortezomib—PSMB1—thyroid gland—bipolar disorder	0.00755	0.0168	CbGeAlD
Bortezomib—PSMB2—thyroid gland—bipolar disorder	0.00736	0.0164	CbGeAlD
Bortezomib—PSMD1—brain—bipolar disorder	0.00714	0.0159	CbGeAlD
Bortezomib—PSMB5—cerebellum—bipolar disorder	0.00683	0.0152	CbGeAlD
Bortezomib—CYP2C8—blood plasma—bipolar disorder	0.00663	0.0148	CbGeAlD
Bortezomib—SLC31A1—thyroid gland—bipolar disorder	0.00638	0.0142	CbGeAlD
Bortezomib—PSMB1—nervous system—bipolar disorder	0.00635	0.0141	CbGeAlD
Bortezomib—PSMD2—brain—bipolar disorder	0.00632	0.0141	CbGeAlD
Bortezomib—PSMB8—brain—bipolar disorder	0.00628	0.014	CbGeAlD
Bortezomib—CYP1A2—blood plasma—bipolar disorder	0.00621	0.0138	CbGeAlD
Bortezomib—PSMB2—nervous system—bipolar disorder	0.00619	0.0138	CbGeAlD
Bortezomib—PSMB1—cerebellum—bipolar disorder	0.00597	0.0133	CbGeAlD
Bortezomib—CYP2C9—blood plasma—bipolar disorder	0.00589	0.0131	CbGeAlD
Bortezomib—PSMB2—cerebellum—bipolar disorder	0.00583	0.013	CbGeAlD
Bortezomib—PSMB5—brain—bipolar disorder	0.00555	0.0123	CbGeAlD
Bortezomib—PTGS1—blood plasma—bipolar disorder	0.00538	0.012	CbGeAlD
Bortezomib—SLC31A1—nervous system—bipolar disorder	0.00536	0.0119	CbGeAlD
Bortezomib—SLC31A1—cerebellum—bipolar disorder	0.00505	0.0112	CbGeAlD
Bortezomib—PSMB1—brain—bipolar disorder	0.00485	0.0108	CbGeAlD
Bortezomib—PSMB2—brain—bipolar disorder	0.00473	0.0105	CbGeAlD
Bortezomib—CYP3A4—blood plasma—bipolar disorder	0.00449	0.01	CbGeAlD
Bortezomib—CYP2D6—blood plasma—bipolar disorder	0.00442	0.00984	CbGeAlD
Bortezomib—SLC31A1—brain—bipolar disorder	0.0041	0.00912	CbGeAlD
Bortezomib—CYP1A2—thyroid gland—bipolar disorder	0.0022	0.00488	CbGeAlD
Bortezomib—CYP1A1—thyroid gland—bipolar disorder	0.00217	0.00482	CbGeAlD
Bortezomib—PTGS1—thyroid gland—bipolar disorder	0.0019	0.00423	CbGeAlD
Bortezomib—CYP1A1—nervous system—bipolar disorder	0.00182	0.00405	CbGeAlD
Bortezomib—PTGS1—nervous system—bipolar disorder	0.0016	0.00356	CbGeAlD
Bortezomib—CYP2C8—brain—bipolar disorder	0.00151	0.00336	CbGeAlD
Bortezomib—CYP1A1—brain—bipolar disorder	0.00139	0.0031	CbGeAlD
Bortezomib—CYP3A4—nervous system—bipolar disorder	0.00134	0.00297	CbGeAlD
Bortezomib—CYP2D6—nervous system—bipolar disorder	0.00132	0.00293	CbGeAlD
Bortezomib—CYP2D6—cerebellum—bipolar disorder	0.00124	0.00275	CbGeAlD
Bortezomib—PTGS1—brain—bipolar disorder	0.00122	0.00272	CbGeAlD
Bortezomib—CYP2D6—brain—bipolar disorder	0.00101	0.00224	CbGeAlD
Bortezomib—PSMB2—Signaling Pathways—TCF7L2—bipolar disorder	0.000119	0.000216	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TCF7L2—bipolar disorder	0.000119	0.000216	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—NDUFV2—bipolar disorder	0.000118	0.000215	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—DRD2—bipolar disorder	0.000118	0.000214	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—DRD2—bipolar disorder	0.000118	0.000214	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—DRD2—bipolar disorder	0.000118	0.000214	CbGpPWpGaD
Bortezomib—PSMB1—Disease—MTHFR—bipolar disorder	0.000118	0.000214	CbGpPWpGaD
Bortezomib—PSMB5—Disease—MTHFR—bipolar disorder	0.000118	0.000214	CbGpPWpGaD
Bortezomib—PSMB2—Disease—MTHFR—bipolar disorder	0.000118	0.000214	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—ADCY2—bipolar disorder	0.000117	0.000213	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TCF7L2—bipolar disorder	0.000117	0.000213	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—DRD2—bipolar disorder	0.000116	0.000211	CbGpPWpGaD
Bortezomib—PSMB8—Disease—MTHFR—bipolar disorder	0.000116	0.000211	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—AKR1C4—bipolar disorder	0.000115	0.000208	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—IMPA1—bipolar disorder	0.000114	0.000208	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—IMPA1—bipolar disorder	0.000113	0.000206	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—NR1D1—bipolar disorder	0.000112	0.000204	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000111	0.000201	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—IMPA2—bipolar disorder	0.000111	0.000201	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000109	0.000198	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—HTR2A—bipolar disorder	0.000109	0.000198	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—HTR2A—bipolar disorder	0.000108	0.000197	CbGpPWpGaD
Bortezomib—CYP1A2—Biological oxidations—POMC—bipolar disorder	0.000108	0.000197	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—CLOCK—bipolar disorder	0.000108	0.000196	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—HTR2A—bipolar disorder	0.000108	0.000196	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—NCAN—bipolar disorder	0.000107	0.000195	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—NTRK1—bipolar disorder	0.000107	0.000194	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—NTRK1—bipolar disorder	0.000107	0.000194	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—NTRK1—bipolar disorder	0.000107	0.000194	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—NDUFV2—bipolar disorder	0.000106	0.000192	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—TPH2—bipolar disorder	0.000105	0.000191	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—CACNB2—bipolar disorder	0.000105	0.000191	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—TSHB—bipolar disorder	0.000105	0.000191	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—SLC5A3—bipolar disorder	0.000105	0.000191	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—NTRK1—bipolar disorder	0.000105	0.000191	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—POMC—bipolar disorder	0.000104	0.000189	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—S100B—bipolar disorder	0.000104	0.000188	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—S100B—bipolar disorder	0.000104	0.000188	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—S100B—bipolar disorder	0.000104	0.000188	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—POMC—bipolar disorder	0.000104	0.000188	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—DPYD—bipolar disorder	0.000104	0.000188	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—INS—bipolar disorder	0.000103	0.000188	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—POMC—bipolar disorder	0.000103	0.000187	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—NR1D1—bipolar disorder	0.000103	0.000187	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—INS—bipolar disorder	0.000103	0.000187	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—GSK3B—bipolar disorder	0.000103	0.000187	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—GSK3B—bipolar disorder	0.000103	0.000187	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—GSK3B—bipolar disorder	0.000103	0.000187	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—INS—bipolar disorder	0.000102	0.000186	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—AKR1C4—bipolar disorder	0.000102	0.000186	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—S100B—bipolar disorder	0.000102	0.000186	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—GSK3B—bipolar disorder	0.000101	0.000184	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—IL1B—bipolar disorder	9.99e-05	0.000181	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—IL1B—bipolar disorder	9.94e-05	0.000181	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—IL1B—bipolar disorder	9.89e-05	0.00018	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—MTHFR—bipolar disorder	9.86e-05	0.000179	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—MTHFR—bipolar disorder	9.86e-05	0.000179	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—MTHFR—bipolar disorder	9.86e-05	0.000179	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—NCAN—bipolar disorder	9.85e-05	0.000179	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—MTHFR—bipolar disorder	9.72e-05	0.000177	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—NDUFV2—bipolar disorder	9.72e-05	0.000177	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—IMPA1—bipolar disorder	9.68e-05	0.000176	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—SLC5A3—bipolar disorder	9.65e-05	0.000175	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—NDUFV2—bipolar disorder	9.63e-05	0.000175	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—CACNA1C—bipolar disorder	9.63e-05	0.000175	CbGpPWpGaD
Bortezomib—PSMB5—Disease—GSK3B—bipolar disorder	9.49e-05	0.000172	CbGpPWpGaD
Bortezomib—PSMB1—Disease—GSK3B—bipolar disorder	9.49e-05	0.000172	CbGpPWpGaD
Bortezomib—PSMB2—Disease—GSK3B—bipolar disorder	9.49e-05	0.000172	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	9.46e-05	0.000172	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—AKR1C4—bipolar disorder	9.41e-05	0.000171	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PIK3C2A—bipolar disorder	9.38e-05	0.00017	CbGpPWpGaD
Bortezomib—PSMB5—Disease—INS—bipolar disorder	9.36e-05	0.00017	CbGpPWpGaD
Bortezomib—PSMB2—Disease—INS—bipolar disorder	9.36e-05	0.00017	CbGpPWpGaD
Bortezomib—PSMB1—Disease—INS—bipolar disorder	9.36e-05	0.00017	CbGpPWpGaD
Bortezomib—PSMB8—Disease—GSK3B—bipolar disorder	9.36e-05	0.00017	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—AKR1C4—bipolar disorder	9.33e-05	0.000169	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	9.26e-05	0.000168	CbGpPWpGaD
Bortezomib—PSMB8—Disease—INS—bipolar disorder	9.23e-05	0.000168	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—NR1D1—bipolar disorder	9.19e-05	0.000167	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—NRG1—bipolar disorder	9.16e-05	0.000166	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—NRG1—bipolar disorder	9.16e-05	0.000166	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—NRG1—bipolar disorder	9.16e-05	0.000166	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—NRG1—bipolar disorder	9.03e-05	0.000164	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—NCAN—bipolar disorder	8.79e-05	0.00016	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—GSK3B—bipolar disorder	8.77e-05	0.000159	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—GSK3B—bipolar disorder	8.73e-05	0.000159	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—POMC—bipolar disorder	8.7e-05	0.000158	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—GSK3B—bipolar disorder	8.69e-05	0.000158	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—POMC—bipolar disorder	8.66e-05	0.000157	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—INS—bipolar disorder	8.65e-05	0.000157	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—POMC—bipolar disorder	8.62e-05	0.000157	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—SLC5A3—bipolar disorder	8.61e-05	0.000156	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—INS—bipolar disorder	8.61e-05	0.000156	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—INS—bipolar disorder	8.57e-05	0.000156	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—NR1D1—bipolar disorder	8.45e-05	0.000154	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—SNAP25—bipolar disorder	8.41e-05	0.000153	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—NR1D1—bipolar disorder	8.38e-05	0.000152	CbGpPWpGaD
Bortezomib—CYP3A4—Biological oxidations—POMC—bipolar disorder	8.36e-05	0.000152	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—HTR2A—bipolar disorder	8.26e-05	0.00015	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—HTR2A—bipolar disorder	8.26e-05	0.00015	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—HTR2A—bipolar disorder	8.26e-05	0.00015	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—NDUFV2—bipolar disorder	8.23e-05	0.00015	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—HTR2A—bipolar disorder	8.14e-05	0.000148	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—NCAN—bipolar disorder	8.09e-05	0.000147	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—NCAN—bipolar disorder	8.02e-05	0.000146	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—AKR1C4—bipolar disorder	7.97e-05	0.000145	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—SLC5A3—bipolar disorder	7.92e-05	0.000144	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—POMC—bipolar disorder	7.88e-05	0.000143	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—POMC—bipolar disorder	7.88e-05	0.000143	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—POMC—bipolar disorder	7.88e-05	0.000143	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—SLC5A3—bipolar disorder	7.85e-05	0.000143	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—INS—bipolar disorder	7.84e-05	0.000142	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—INS—bipolar disorder	7.84e-05	0.000142	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—INS—bipolar disorder	7.84e-05	0.000142	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—POMC—bipolar disorder	7.77e-05	0.000141	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—INS—bipolar disorder	7.73e-05	0.00014	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CLOCK—bipolar disorder	7.61e-05	0.000138	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL1B—bipolar disorder	7.57e-05	0.000137	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL1B—bipolar disorder	7.57e-05	0.000137	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL1B—bipolar disorder	7.57e-05	0.000137	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—IMPA1—bipolar disorder	7.47e-05	0.000136	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IL1B—bipolar disorder	7.46e-05	0.000136	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—ADCY2—bipolar disorder	7.45e-05	0.000135	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CACNB2—bipolar disorder	7.42e-05	0.000135	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—TPH2—bipolar disorder	7.42e-05	0.000135	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—TSHB—bipolar disorder	7.42e-05	0.000135	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—DPYD—bipolar disorder	7.3e-05	0.000133	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—NR1D1—bipolar disorder	7.16e-05	0.00013	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CLOCK—bipolar disorder	6.98e-05	0.000127	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—NCAN—bipolar disorder	6.85e-05	0.000124	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—TSHB—bipolar disorder	6.8e-05	0.000123	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—TPH2—bipolar disorder	6.8e-05	0.000123	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CACNB2—bipolar disorder	6.8e-05	0.000123	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CACNA1C—bipolar disorder	6.78e-05	0.000123	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—SLC5A3—bipolar disorder	6.71e-05	0.000122	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—DPYD—bipolar disorder	6.69e-05	0.000121	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—GSK3B—bipolar disorder	6.65e-05	0.000121	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—GSK3B—bipolar disorder	6.65e-05	0.000121	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—GSK3B—bipolar disorder	6.65e-05	0.000121	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PIK3C2A—bipolar disorder	6.61e-05	0.00012	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—POMC—bipolar disorder	6.59e-05	0.00012	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—POMC—bipolar disorder	6.59e-05	0.00012	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—POMC—bipolar disorder	6.59e-05	0.00012	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—INS—bipolar disorder	6.56e-05	0.000119	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—INS—bipolar disorder	6.56e-05	0.000119	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—INS—bipolar disorder	6.56e-05	0.000119	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—GSK3B—bipolar disorder	6.55e-05	0.000119	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	6.52e-05	0.000118	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—POMC—bipolar disorder	6.5e-05	0.000118	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—INS—bipolar disorder	6.46e-05	0.000117	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—COMT—bipolar disorder	6.38e-05	0.000116	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NDUFV2—bipolar disorder	6.35e-05	0.000115	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—MAOA—bipolar disorder	6.33e-05	0.000115	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CLOCK—bipolar disorder	6.23e-05	0.000113	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CACNA1C—bipolar disorder	6.22e-05	0.000113	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—AKR1C4—bipolar disorder	6.15e-05	0.000112	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—TSHB—bipolar disorder	6.07e-05	0.00011	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—TPH2—bipolar disorder	6.07e-05	0.00011	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CACNB2—bipolar disorder	6.07e-05	0.00011	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PIK3C2A—bipolar disorder	6.06e-05	0.00011	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	5.98e-05	0.000109	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—DPYD—bipolar disorder	5.97e-05	0.000108	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—SNAP25—bipolar disorder	5.93e-05	0.000108	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CLOCK—bipolar disorder	5.73e-05	0.000104	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CLOCK—bipolar disorder	5.68e-05	0.000103	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—TPH2—bipolar disorder	5.58e-05	0.000101	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—TSHB—bipolar disorder	5.58e-05	0.000101	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CACNB2—bipolar disorder	5.58e-05	0.000101	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CACNA1C—bipolar disorder	5.55e-05	0.000101	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—TPH2—bipolar disorder	5.53e-05	0.000101	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—TSHB—bipolar disorder	5.53e-05	0.000101	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CACNB2—bipolar disorder	5.53e-05	0.000101	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NR1D1—bipolar disorder	5.53e-05	0.0001	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—DPYD—bipolar disorder	5.49e-05	9.97e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—DPYD—bipolar disorder	5.44e-05	9.89e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—SNAP25—bipolar disorder	5.43e-05	9.87e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	5.41e-05	9.82e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	5.34e-05	9.69e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NCAN—bipolar disorder	5.29e-05	9.6e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ADCY2—bipolar disorder	5.25e-05	9.53e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SLC5A3—bipolar disorder	5.18e-05	9.41e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—MTHFR—bipolar disorder	5.15e-05	9.36e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CACNA1C—bipolar disorder	5.1e-05	9.27e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CACNA1C—bipolar disorder	5.06e-05	9.19e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	4.97e-05	9.04e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	4.93e-05	8.96e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	4.87e-05	8.84e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CLOCK—bipolar disorder	4.85e-05	8.81e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—SNAP25—bipolar disorder	4.85e-05	8.81e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ADCY2—bipolar disorder	4.81e-05	8.74e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—TPH2—bipolar disorder	4.73e-05	8.59e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CACNB2—bipolar disorder	4.73e-05	8.59e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—TSHB—bipolar disorder	4.73e-05	8.59e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—DPYD—bipolar disorder	4.65e-05	8.45e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—COMT—bipolar disorder	4.49e-05	8.16e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—SNAP25—bipolar disorder	4.46e-05	8.1e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—MAOA—bipolar disorder	4.46e-05	8.1e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—SNAP25—bipolar disorder	4.42e-05	8.03e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CACNA1C—bipolar disorder	4.32e-05	7.86e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ADCY2—bipolar disorder	4.29e-05	7.8e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	4.21e-05	7.65e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	4.16e-05	7.55e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—POMC—bipolar disorder	4.12e-05	7.49e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—COMT—bipolar disorder	4.12e-05	7.48e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—INS—bipolar disorder	4.1e-05	7.45e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—MAOA—bipolar disorder	4.09e-05	7.43e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ADCY2—bipolar disorder	3.95e-05	7.17e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ADCY2—bipolar disorder	3.91e-05	7.11e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—SNAP25—bipolar disorder	3.78e-05	6.87e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CLOCK—bipolar disorder	3.74e-05	6.8e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—COMT—bipolar disorder	3.68e-05	6.68e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—MAOA—bipolar disorder	3.65e-05	6.63e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—TPH2—bipolar disorder	3.65e-05	6.63e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—TSHB—bipolar disorder	3.65e-05	6.63e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CACNB2—bipolar disorder	3.65e-05	6.63e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—MTHFR—bipolar disorder	3.63e-05	6.6e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—DPYD—bipolar disorder	3.59e-05	6.52e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—COMT—bipolar disorder	3.38e-05	6.14e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—MAOA—bipolar disorder	3.36e-05	6.1e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—COMT—bipolar disorder	3.35e-05	6.09e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ADCY2—bipolar disorder	3.35e-05	6.08e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CACNA1C—bipolar disorder	3.34e-05	6.06e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—MTHFR—bipolar disorder	3.33e-05	6.05e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—MAOA—bipolar disorder	3.33e-05	6.05e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	3.25e-05	5.91e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—MTHFR—bipolar disorder	2.97e-05	5.4e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SNAP25—bipolar disorder	2.92e-05	5.3e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—POMC—bipolar disorder	2.9e-05	5.28e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—INS—bipolar disorder	2.89e-05	5.25e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—COMT—bipolar disorder	2.86e-05	5.2e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—MAOA—bipolar disorder	2.84e-05	5.17e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—MTHFR—bipolar disorder	2.73e-05	4.96e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—MTHFR—bipolar disorder	2.71e-05	4.92e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—POMC—bipolar disorder	2.66e-05	4.84e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—INS—bipolar disorder	2.65e-05	4.81e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ADCY2—bipolar disorder	2.58e-05	4.69e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—POMC—bipolar disorder	2.38e-05	4.32e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—INS—bipolar disorder	2.36e-05	4.29e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—MTHFR—bipolar disorder	2.32e-05	4.21e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—COMT—bipolar disorder	2.21e-05	4.02e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—MAOA—bipolar disorder	2.2e-05	3.99e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—POMC—bipolar disorder	2.19e-05	3.97e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—INS—bipolar disorder	2.17e-05	3.95e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—POMC—bipolar disorder	2.17e-05	3.94e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—INS—bipolar disorder	2.16e-05	3.91e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—POMC—bipolar disorder	1.85e-05	3.36e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—INS—bipolar disorder	1.84e-05	3.35e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—MTHFR—bipolar disorder	1.79e-05	3.25e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—POMC—bipolar disorder	1.43e-05	2.6e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—INS—bipolar disorder	1.42e-05	2.58e-05	CbGpPWpGaD
